[1]
M. J. Railo, K. v Smitten, and F. Pekonen, “The Prognostic Value of Epidermal Growth Factor Receptor (EGFR) in Breast Cancer Patients: Results of a follow-up study on 149 patients”, AO, vol. 33, no. 1, pp. 13–17, Jan. 1994.